Free. Unsubscribe any time.
Verona Pharma plc (VRNA)
Verona Pharma plc filed 21 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 32 transactions and 4,248,728 shares. None carries the SEC's AFF10B5ONE flag; all 21 name a plan in a footnote. 3 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2025-08-05, came on the same day as the one before it (2025-08-05) and reports 4 transactions against 4 in the filing before it.
- The sales it reports total 208,912 shares, 150,576 more than the 58,336 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 21 filings on file run from 2025-03-13 to 2025-08-05, and state 7 plan adoption dates, from 2021-05-14 to 2025-02-12.
Trades in Verona Pharma plc 32
- Rickard Kathleen A. — 2025-03-12 · S · 79,264 shares
- Hahn Mark W — 2025-04-29 · S · 90,360 shares
- Rickard Kathleen A. — 2025-04-29 · S · 34,384 shares
- Sinha Vikas — 2025-04-29 · S · 15,048 shares
- Sinha Vikas — 2025-04-29 · S · 4,952 shares
- Sinha Vikas — 2025-04-29 · S · 120,384 shares
- Sinha Vikas — 2025-04-29 · S · 39,616 shares
- ZACCARDELLI DAVID — 2025-04-29 · S · 90,360 shares
- Hahn Mark W — 2025-05-01 · S · 108,272 shares
- Hahn Mark W — 2025-05-01 · S · 78,736 shares
- Rickard Kathleen A. — 2025-05-01 · S · 27,336 shares
- Rickard Kathleen A. — 2025-05-01 · S · 21,864 shares
Adoption dates in Verona Pharma plc 7
- 2021-05-14 — stated in 3 filings
- 2022-05-24 — stated in 6 filings
- 2024-11-06 — stated in 3 filings
- 2024-12-11 — stated in 2 filings
- 2025-01-15 — stated in 2 filings
- 2025-01-29 — stated in 4 filings
- 2025-02-12 — stated in 1 filing
Results prints in Verona Pharma plc 3
- 2025-01-07
- 2025-02-27
- 2025-04-29
Trades before a print in Verona Pharma plc 7
- 0 days before the 2025-04-29 print — 2025-04-29 · S · Hahn Mark W · 90,360 shares
- 0 days before the 2025-04-29 print — 2025-04-29 · S · Rickard Kathleen A. · 34,384 shares
- 0 days before the 2025-04-29 print — 2025-04-29 · S · Sinha Vikas · 15,048 shares
- 0 days before the 2025-04-29 print — 2025-04-29 · S · Sinha Vikas · 4,952 shares
- 0 days before the 2025-04-29 print — 2025-04-29 · S · Sinha Vikas · 120,384 shares
- 0 days before the 2025-04-29 print — 2025-04-29 · S · Sinha Vikas · 39,616 shares
- 0 days before the 2025-04-29 print — 2025-04-29 · S · ZACCARDELLI DAVID · 90,360 shares
- 48 days before the 2025-04-29 print — 2025-03-12 · S · Rickard Kathleen A. · 79,264 shares
Interval to Verona Pharma plc’s next reported results date
How the interval and sources are counted →
- 7within 5 days
- 7within 10 days
- 0shortest, days
- 24no later print
- Hahn Mark W 2025-04-29 · S · 0 days before the 2025-04-29 print · Chief Financial Officer
- Rickard Kathleen A. 2025-04-29 · S · 0 days before the 2025-04-29 print · Chief Medical Officer
- Sinha Vikas 2025-04-29 · S · 0 days before the 2025-04-29 print
- Sinha Vikas 2025-04-29 · S · 0 days before the 2025-04-29 print
- Sinha Vikas 2025-04-29 · S · 0 days before the 2025-04-29 print
- Sinha Vikas 2025-04-29 · S · 0 days before the 2025-04-29 print
- ZACCARDELLI DAVID 2025-04-29 · S · 0 days before the 2025-04-29 print · President and CEO
Adoption dates Verona Pharma plc states
- 2021-05-14 in 3 filings
- 2022-05-24 in 6 filings
- 2024-11-06 in 3 filings
- 2024-12-11 in 2 filings
- 2025-01-15 in 2 filings
- 2025-01-29 in 4 filings
- 2025-02-12 in 1 filing
Filing text: “10b5-1 plan adopted on December 11, 2024”
Reported results dates on file
- 2025-01-07
- 2025-02-27
- 2025-04-29
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.